David Hollander - Jul 1, 2024 Form 4 Insider Report for KIORA PHARMACEUTICALS INC (KPRX)

Role
Director
Signature
/s/ Melissa Tosca, Attorney-in-Fact
Stock symbol
KPRX
Transactions as of
Jul 1, 2024
Transactions value $
$0
Form type
4
Date filed
7/3/2024, 03:15 PM
Previous filing
Feb 29, 2024
Next filing
Nov 19, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KPRX Stock Option (right to buy) Award $0 +1.78K $0.00 1.78K Jul 1, 2024 Common Stock 1.78K $4.35 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan. The Option will become fully exercisable on July 1, 2025.